Keywords Index (2000-2004)

[A] [B] [C] [D] [E] [F] [G] [H] [I] [L] [M] [N] [O] [P] [R] [S] [T] [V]

A

• Acetylcarnitine 3(1) 23-34
• Alpha-linolenic acid 2(2) 39-43, 2(1) 13-19
• AMD 1(1) 40-44
• Antiatherogenic 2(1) 21-35
• Anticarcinogenic 2(1) 21-35
• Antimicrobial effect 3(3) 11-16
• Antimutagenic 1(1) 27-39
• Antioxidant 1(1) 27-39, 2(1) 21-35
• Antioxidant capacity 3(2) 05-11, 3(3) 19-26
• ATCC 55730 3(3) 37-49

to top

B

• Balsamodendron 2(2) 45-51
• Bifidobacterium 2(2) 13-21, 1(1) 05-11
• Biomarkers 2(1) 05-12
• Body mass index 3(3) 27-35
• Bone health 3(3) 05-09, 3(3) 27-35
• Bone mineral density 3(3) 27-35
• Breastfeeding 3(2) 13-21
• Breast milk 3(2) 13-21

to top

C

• Calicum 3(3) 05-09
• Cancer 2(1) 21-35, 3(1) 5-13
• Cardiovascular 2(2) 45-51
• Carnitine 3(1) 23-34
• Carotenoids 1(1) 40-44, 2(1) 21-35
• Cataract 1(1) 40-44
• Catechins 3(2) 05-11
• Cell culture 2(1) 05-12
• Cholesterol 3(2) 23-29
• Cholesterol metabolism 2(2) 05-11
• Citrus 1(1) 27-39
• Clinical trials 1(1) 05-11, 3(1) 15-22, 3(1) 35-39
• Colonic fermentation 3(1) 35-39
• Colonization 3(1) 15-22
• Commiphora mukul 2(2) 45-51
• Commiphora wightii 2(2) 45-51
• Coronary heart disease 2(1) 21-35
• Creatine 3(1) 23-34
• CVD 3(2) 23-29

to top

D

• Derogation 2(1) 37-41
• Diet 3(1) 35-39
• Dislipidemia 2(2) 45-51
• Docosahexanoic acid 2(1) 13-19, 2(2) 39-43
• DSHEA 1(1) 13-26
• D-lactic acid 3(3) 37-49

to top

E

• Eicosanoids 2(2) 39-43
• Eicosapentanoic acid 2(1) 13-19, 2(2) 39-43
• Energy 3(1) 23-34
• Exogenous factors 3(3) 05-09
• Extract standardization 2(2) 45-51

to top

F

• FDAMA 1(1) 13-26
• Flavan-3-ols 1(1) 27-39
• Flavonoids 1(1) 27-39
• Folate 3(1) 5-13
• Folic acid 3(1) 5-13
• Food-borne pathogens 3(3) 11-16
• Food fortification 3(1) 5-13
• Food supplements 2(1) 37-41
• Free radicals 3(2) 05-11
• Functional foods 2(2) 05-11, 2(2) 13-21, 2(2) 23-37, 3(2) 23-29

to top

G

• Gastroenteritis 3(1) 15-22
• Gugulipid 2(2) 45-51

to top

H

• Health claims 1(1) 13-26
• Heart disease 1(1) 40-44
• Hemorrhoids 3(3) 19-26
• Homocysteine 2(1) 13-19, 3(1) 5-13
• Hydrogen excretion 3(1) 35-39
• Hypercholesterolemia 2(2) 5-11, 3(2) 23-29

to top

I

• Immunity 2(2) 39-43
• Intestinal health 2(1) 5-12
• Irritable bowel syndrome 3(1) 35-39

to top

L

• Lactic acid bacteria 3(2) 13-21, 3(3) 11-16
• Lactobacilli 3(3) 37-49
• Lactobacillus 1(1) 5-11, 3(2) 13-21
• Lactobacillus reuteri 3(1) 15-22, 3(3) 37-49
• Large intestine 2(1) 5-12
• Linoleic acid 2(2) 39-43
• Lipoprotein 2(2) 5-11
• Lutein 1(1) 40-44
• Lycopene, pharmacokinetics of 2(1) 21-35

to top

M

• Market models 1(1) 13-26
• Metabolic fingerprinting 2(1) 5-12
• Micronutrients 3(3) 05-09
• Milk 2(2) 23-37

to top

N

• Natural food 2(2) 23-37
• Neural tube defects 3(1) 5-13
• NLEA 1(1) 13-26
• NMR 2(1) 5-12
• Nutrient safety 2(1) 37-41
• Nutrition 3(3) 05-09, 3(3) 27-35
• n-3 Fatty acids sto topplemented foods 2(1) 13-19

to top

O

• Octacosanol 3(1) 23-34
• Olive oil 2(2) 23-37
• Osteocalcin 3(3) 27-35
• Osteoporosis 3(3) 27-35

to top

P

• Peptides 3(3) 11-16
• Photochemiluminescence 3(2) 05-11, 3(3) 19-26
• Phytostanols 3(2) 23-29
• Phytosterols 3(2) 23-29
• Plant sterols 2(2) 5-11
• Prebiotics 2(1) 5-12
• Probiotics 1(1) 5-11, 2(2) 13-21, 3(1) 15-22, 3(2) 13-21, 3(3) 37-49
• Probiotic bacteria 3(1) 35-39
• Probiotics culture 3(3) 11-16
• Public health 3(3) 05-09

to top

R

• Radioprotection 1(1) 27-39
• ROS 3(2) 05-11

to top

S

• Saccharomyces 1(1) 5-11
• Safety 3(3) 37-49
• Supplement labelling 2(1) 37-41

to top

T

• Tea 3(2) 05-11
• Theaflavins 3(2) 05-11
• TIM-2 model 2(1) 5-12
• Tocotrienols 3(3) 19-26

to top

V

• Vitamin D 3(3) 05-09
• Vitis 1(1) 27-39

to top